Skip to main content

AgoraSign in

Andrew R. Garbarino

Sponsor · U.S. Representative, NY-2 · Republican

Follow

House bill · H.R. 1922 (119th Congress)

Ensuring Access to Essential Drugs Act

Latest action Mar 6, 2025

Summary

Ensuring Access to Essential Drugs Act This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit. Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).

Your position on this bill

Not chosen yet

Sign in to choose

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Full history

  1. Mar 6, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Mar 6, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Mar 6, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Mar 6, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Mar 6, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

About this record

Summary

The summary is written by the Congressional Research Service. For more, see How we handle summaries.

Cosponsors

The cosponsors are the ones listed on Congress.gov, shown A to Z.

Party colors

Parties are shown in the same neutral colors.

Source

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Read the record

Follow